{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:06:35Z","timestamp":1793214395025,"version":"4.5.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is neurodegenerative disease in middle-aged and elderly people with some pathological mechanisms including immune disorder, neuroinflammation, white matter injury and abnormal aggregation of alpha-synuclein, etc. New research suggests that white matter injury may be important in the development of PD, but how inflammation, the immune system, and white matter damage interact to harm dopamine neurons is not yet understood. Therefore, it is particularly important to delve into the crosstalk between immune cells in the central and peripheral nervous system based on the study of white matter damage in PD. This crosstalk could not only exacerbate the pathological process of PD but may also reveal new therapeutic targets. By understanding how immune cells penetrate through the blood\u2013brain barrier and activate inflammatory responses within the central nervous system, we can better grasp the impact of structural destruction of white matter in PD and explore how this process can be modulated to mitigate or combat disease progression. Microglia, astrocytes, oligodendrocytes and peripheral immune cells (especially T cells) play a central role in its pathological process where these immune cells produce and respond to pro-inflammatory cytokines such as tumor necrosis factor (TNF-\u03b1), interleukin-1\u03b2(IL-1\u03b2) and interleukin-6(IL-6), and white matter injury causes microglia to become pro-inflammatory and release inflammatory mediators, which attract more immune cells to the damaged area, increasing the inflammatory response. Moreover, white matter damage also causes dysfunction of blood\u2013brain barrier, allows peripheral immune cells and inflammatory factors to invade the brain further, and enhances microglia activation forming a vicious circle that intensifies neuroinflammation. And these factors collectively promote the neuroinflammatory environment and neurodegeneration changes of PD. Overall, these findings not only deepen our understanding of the complexity of PD, but also provide new targets for the development of therapeutic strategies focused on inflammation and immune regulation mechanisms. In summary, this review provided the theoretical basis for clarifying the pathogenesis of PD, summarized the association between white matter damage and the immune cells in the central and peripheral nervous systems, and then emphasized their potential specific mechanisms of achieving crosstalk with further aggravating the pathological process of PD.<\/jats:p>","DOI":"10.3389\/fnagi.2024.1345918","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:15:46Z","timestamp":1716873346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The mechanisms of white matter injury and immune system crosstalk in promoting the progression of Parkinson\u2019s disease: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Wen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/glia.22575","article-title":"Glial influence on the blood brain barrier","volume":"61","author":"Alvarez","year":"2013","journal-title":"Glia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13041-023-01055-5","article-title":"Changes in oligodendroglial subpopulations in Parkinson's disease","volume":"16","author":"Bae","year":"2023","journal-title":"Mol. Brain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2018.11.006","article-title":"The CNS immune-privilege Goes down the drain(age)","volume":"40","author":"Brioschi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/jci36470","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/glia.22674","article-title":"Neurotransmitter signaling in white matter","volume":"62","author":"Butt","year":"2014","journal-title":"Glia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson's disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.pneurobio.2020.101845","article-title":"White matter injury and neurodevelopmental disabilities: a cross-disease (dis)connection","volume":"193","author":"Cainelli","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12868-017-0367-y","article-title":"White matter damage and systemic inflammation in Parkinson's disease","volume":"18","author":"Chiang","year":"2017","journal-title":"BMC Neurosci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1161\/strokeaha.112.657130","article-title":"Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs","volume":"43","author":"de Laat","year":"2012","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer's disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease","volume":"12","author":"di Domenico","year":"2019","journal-title":"Stem cell reports."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-014-0090-1","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12974-018-1202-9","article-title":"Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-1","article-title":"Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)","volume":"9","author":"Durrenberger","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1161\/strokeaha.115.010351","article-title":"White matter injury after subarachnoid hemorrhage: role of blood-brain barrier disruption and matrix Metalloproteinase-9","volume":"46","author":"Egashira","year":"2015","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"554613","DOI":"10.3389\/fncel.2020.554613","article-title":"N-acetylcysteine rescues hippocampal oxidative stress-induced neuronal injury via suppression of p38\/JNK signaling in depressed rats","volume":"14","author":"Fan","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tins.2023.11.003","article-title":"White matter injury across neurodegenerative disease","volume":"47","author":"Festa","year":"2024","journal-title":"Trends Neurosci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13578-023-01126-z","article-title":"Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke","volume":"13","author":"Gao","year":"2023","journal-title":"Cell Biosci."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12035-021-02571-y","article-title":"Ferrostatin-1 alleviates White matter injury via decreasing Ferroptosis following spinal cord injury","volume":"59","author":"Ge","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1758-5996-6-80","article-title":"Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases","volume":"6","author":"Gomes","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-024-00713-z","article-title":"GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice","volume":"19","author":"Gregorio","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol. Brain"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1083159","DOI":"10.3389\/fncel.2022.1083159","article-title":"Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases","volume":"16","author":"Han","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mt.2010.217","article-title":"Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"19","author":"Harms","year":"2011","journal-title":"Molecular therapy: J. American Society of Gene Therapy."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson's disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1034\/j.1600-0404.2000.101003159.x","article-title":"Impaired cytokine production by peripheral blood mononuclear cells and monocytes\/macrophages in Parkinson's disease","volume":"101","author":"Hasegawa","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/archneur.58.10.1580","article-title":"Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease","volume":"58","author":"Hisanaga","year":"2001","journal-title":"Arch. Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/biom11071058","article-title":"Oligodendrocytes and microglia: key players in myelin development, damage and repair","volume":"11","author":"Kalafatakis","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.4049\/jimmunol.1400716","article-title":"Ontogeny and functions of central nervous system macrophages","volume":"193","author":"Katsumoto","year":"2014","journal-title":"J. Immunol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/glia.22690","article-title":"Traumatic white matter injury and glial activation: from basic science to clinics","volume":"62","author":"Kou","year":"2014","journal-title":"Glia"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1073\/pnas.1322174111","article-title":"Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans","volume":"111","author":"Kox","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease","volume":"59","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Acta Neurobiol. Exp."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Translational neurodegeneration."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnmol.2016.00089","article-title":"Protective microglia and their regulation in Parkinson's disease","volume":"9","author":"Le","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.3390\/ijms21197152","article-title":"Neuroprotective effect of antioxidants in the brain","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1032140","DOI":"10.3389\/fnins.2022.1032140","article-title":"The emerging roles of ferroptosis in cells of the central nervous system","volume":"16","author":"Li","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","article-title":"CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature","volume":"21","author":"Louveau","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1278323","DOI":"10.3389\/fnagi.2023.1278323","article-title":"Research progress of ferroptosis in Parkinson's disease: a bibliometric and visual analysis","volume":"15","author":"Lu","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1080\/15548627.2021.2016256","article-title":"Autophagy mediates the clearance of oligodendroglial SNCA\/alpha-synuclein and TPPP\/p25A in multiple system atrophy models","volume":"18","author":"Mavroeidi","year":"2022","journal-title":"Autophagy"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"","journal-title":"Neurosci. Lett."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"","journal-title":"Neurosci. Lett."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-7091-6284-2_12","article-title":"Cytokines in Parkinson's disease","volume":"58","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40035-022-00332-y","article-title":"Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity","volume":"11","author":"Ng","year":"2022","journal-title":"Translational neurodegeneration."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ana.410220415","article-title":"On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics","volume":"22","author":"Nutt","year":"1987","journal-title":"Ann. Neurol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"103380","DOI":"10.1016\/j.ebiom.2021.103380","article-title":"Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease","volume":"67","author":"Olson","year":"2021","journal-title":"EBioMedicine"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1001\/jamaneurol.2021.3996","article-title":"Association of White Matter Hyperintensities with Pathology and Progression of parkinsonism in aging","volume":"78","author":"Oveisgharan","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2010.02.018","article-title":"Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression","volume":"222","author":"Pott Godoy","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain J. Neurol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1586\/14737175.2014.868306","article-title":"Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions","volume":"14","author":"Ramirez-Zamora","year":"2014","journal-title":"Expert. Rev. Neurother."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/cns.13221","article-title":"White matter T2 hyperintensities and blood-brain barrier disruption in the hyperacute stage of subarachnoid hemorrhage in male mice: the role of lipocalin-2","volume":"25","author":"Toyota","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/b978-0-12-398314-5.00004-0","article-title":"Inflammation in Parkinson's disease","volume":"88","author":"Tufekci","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1111\/febs.14323","article-title":"Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease","volume":"285","author":"Vilalta","year":"2018","journal-title":"FEBS J."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn1722","article-title":"Astrocytes, from brain glue to communication elements: the revolution continues","volume":"6","author":"Volterra","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/cells12192336","article-title":"Astrocytes in Parkinson's disease: from role to possible intervention","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation","volume":"10","author":"Wang","year":"2021","journal-title":"Translational neurodegeneration."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson's disease: glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41423-022-00941-7","article-title":"Ferroptosis drives immune-mediated neurodegeneration in multiple sclerosis","volume":"20","author":"White","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"659584","DOI":"10.3389\/fphar.2021.659584","article-title":"Ferroptosis as a new mechanism in Parkinson's disease therapy using traditional Chinese medicine","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.3390\/ijms22147710","article-title":"Blood-brain barrier and neurodegenerative diseases-modeling with iPSC-derived brain cells","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12920-023-01481-3","article-title":"Identification of ferroptosis related biomarkers and immune infiltration in Parkinson's disease by integrated bioinformatic analysis","volume":"16","author":"Xing","year":"2023","journal-title":"BMC Med. Genet."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12883-021-02250-4","article-title":"Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a case report","volume":"21","author":"Yan","year":"2021","journal-title":"BMC Neurol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41531-023-00592-z","article-title":"White matter changes in Parkinson's disease","volume":"9","author":"Yang","year":"2023","journal-title":"NPJ Parkinson's Dis."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1281763","DOI":"10.3389\/fncel.2023.1281763","article-title":"CD8(+) T cells in brain injury and neurodegeneration","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7150\/thno.35841","article-title":"Microglia exacerbate white matter injury via complement C3\/C3aR pathway after hypoperfusion","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/s41380-019-0569-z","article-title":"Large-scale GWAS reveals genetic architecture of brain white matter microstructure and genetic overlap with cognitive and mental health traits (n\u2009=\u200917,706)","volume":"26","author":"Zhao","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10072-022-06494-x","article-title":"Assessing the association between white matter lesions and Parkinson's disease","volume":"44","author":"Zhu","year":"2023","journal-title":"Neurological Sci.: Official J. Italian Neurolog. Society and of the Italian Society of Clin. Neurophysiol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1345918\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:15:49Z","timestamp":1716873349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1345918\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":95,"alternative-id":["10.3389\/fnagi.2024.1345918"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1345918","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"article-number":"1345918"}}